Elanco targets $1.15B innovation revenue in 2026 as Big 6 launches gain momentum
Source: SeekingAlpha
2026-02-24 12:38:48 ET
More on Elanco
- Elanco Animal Health Incorporated (ELAN) Q4 2025 Earnings Call Transcript
- Elanco Animal Health Incorporated 2025 Q4 - Results - Earnings Call Presentation
- Elanco Animal Health Incorporated (ELAN) Presents at 44th Annual J.P. Morgan Healthcare Conference Presentation
- Elanco hits 52-week high after Q4 results as 2026 outlook beats consensus
- Elanco Non-GAAP EPS of $0.13 beats by $0.02, revenue of $1.14B beats by $50M
Read the full article on Seeking Alpha
For further details see:
Elanco targets $1.15B innovation revenue in 2026 as Big 6 launches gain momentum
Elanco Animal Health Incorporated
NASDAQ: ELAN
ELAN Trading
3.55% G/L:
$24.18 Last:
1,262,530 Volume:
$24.01 Open:
ELAN Latest News
February 24, 2026 06:27:00 am
Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results
ELAN Stock Data
$12,716,326,237
491,894,838
0.21%
216
N/A
Pharmaceuticals
Healthcare
US
Indianapolis
